Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

Journal of Hepatology

Volumn 65, Issue 1, 2016, Pages 57-65

  Ariza, X ^a,b,c   Graupera, I ^a,b,c   Coll, M ^b,c   Sola E ^a,b,c   Barreto, R ^a,b,c   Garcia E ^d   Moreira, R ^a,b,c   Elia, C ^a,b,c   Morales Ruiz, M ^a,b,c,e   Llopis, M ^b,c   Huelin, P ^a,b,c   Sole C ^a,b,c   Fabrellas, N ^a,b   Weiss, E ^f,g,h,i   Nevens, F ^j   Gerbes, A ^k   Trebicka, J ^l   Saliba, F ^m   Fondevila, C ^a,b,c,e   Hernandez Gea V ^a,b,c,e   Fernandez J ^a,b,c   Bernardi, M ⁿ   Arroyo, V ^o   Jimenez W ^a,b,c,e   Deulofeu, C ^d   Pavesi, M ^c,d   Angeli, P ^p   Jalan, R ^q   Moreau, R ^f,g,h,i   Sancho Bru, P ^b,c   Gines P ^a,b,c   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Data Management Centre   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h BEAUJON HOSPITAL   (France)

ⁱ Laboratoire d'Excellence INFLAMEX   (France)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSITY OF BONN   (Germany)

^m HÔPITAL PAUL BROUSSE   (France)

ⁿ UNIVERSITY OF BOLOGNA   (Italy)

^o CLIF Consortium Data Management   (Spain)

^p UNIVERSITY OF PADOVA   (Italy)

^q ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

Acute on chronic liver failure; Biomarker; Lipocalin 2; NGAL

Indexed keywords

BILIRUBIN; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; BIOLOGICAL MARKER;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENE; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; UPREGULATION; ACUTE KIDNEY FAILURE;

ACUTE KIDNEY INJURY; ACUTE-ON-CHRONIC LIVER FAILURE; BIOMARKERS; HUMANS; LIPOCALIN-2; LIVER CIRRHOSIS; PROGNOSIS;

EID: 84964813107     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.03.002     Document Type: Article

References (35)

1. S. Chakraborty, S. Kaur, S. Guha, and S.K. Batra The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer Biochim Biophys Acta 1826 2012 129 169
2. J.B. Cowland, and N. Borregaard Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans Genomics 45 1997 17 23
3. D.H. Goetz, M.A. Holmes, N. Borregaard, M.E. Bluhm, K.N. Raymond, and R.K. Strong The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Mol Cell 10 2002 1033 1043
4. T.H. Flo, K.D. Smith, S. Sato, D.J. Rodriguez, M.A. Holmes, R.K. Strong, and et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron Nature 432 2004 917 921
5. K.M. Schmidt-Ott, K. Mori, J.Y. Li, A. Kalandadze, D.J. Cohen, P. Devarajan, and et al. Dual action of neutrophil gelatinase-associated lipocalin J Am Soc Nephrol 18 2007 407 413
6. J. Mishra, Q. Ma, A. Prada, M. Mitsnefes, K. Zahedi, J. Yang, and et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury J Am Soc Nephrol 14 2003 2534 2543
7. S. Supavekin, W. Zhang, R. Kucherlapati, F.J. Kaskel, L.C. Moore, and P. Devarajan Differential gene expression following early renal ischemia/reperfusion Kidney Int 63 2003 1714 1724
8. N. Paragas, A. Qiu, Q. Zhang, B. Samstein, S.X. Deng, K.M. Schmidt-Ott, and et al. The Ngal reporter mouse detects the response of the kidney to injury in real time Nat Med 17 2011 216 222
9. J.L. Alge, and J.M. Arthur Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications Clin J Am Soc Nephrol 10 2015 147 155
10. T.L. Nickolas, M.J. O'Rourke, J. Yang, M.E. Sise, P.A. Canetta, N. Barasch, and et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury Ann Intern Med 148 2008 810 819
11. T.L. Nickolas, K.M. Schmidt-Ott, P. Canetta, C. Forster, E. Singer, M. Sise, and et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study J Am Coll Cardiol 59 2012 246 255
12. J.L. Koyner, and C.R. Parikh Clinical utility of biomarkers of AKI in cardiac surgery and critical illness Clin J Am Soc Nephrol 8 2013 1034 1042
13. E. Borkham-Kamphorst, F. Drews, and R. Weiskirchen Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation Liver Int 31 2011 656 665
14. E. Borkham-Kamphorst, E. van de Leur, H.W. Zimmermann, K.R. Karlmark, L. Tihaa, U. Haas, and et al. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis Biochim Biophys Acta 1832 2013 660 673
15. K. Labbus, M. Henning, E. Borkham-Kamphorst, C. Geisler, T. Berger, T.W. Mak, and et al. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions J Proteomics 78 2013 188 196
16. M.J. Xu, D. Feng, H. Wu, H. Wang, Y. Chan, J. Kolls, and et al. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3 Hepatology 61 2015 692 702
17. T. Auguet, X. Terra, Y. Quintero, S. Martínez, N. Manresa, J.A. Porras, and et al. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease Exp Clin Endocrinol Diabetes 121 2013 119 124
18. R. Moreau, R. Jalan, P. Ginès, M. Pavesi, P. Angeli, J. Cordoba, et al. CANONIC Study Investigators of the EASL-CLIF Consortium Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1426 1437
19. V. Arroyo, R. Moreau, R. Jalan, P. Ginès EASL-CLIF Consortium CANONIC Study Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis J Hepatol 62 2015 S131 S143
20. A.S. Decavele, L. Dhondt, M.L. De Buyzere, and J.R. Delanghe Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia Clin Chem Lab Med 49 2011 999 1003
21. J. Bosch, J.C. Garcia-Pagán, A. Berzigotti, and J.G. Abraldes Measurement of portal pressure and its role in the management of chronic liver disease Semin Liver Dis 26 2006 348 362
22. R. Jalan, F. Saliba, M. Pavesi, A. Amorós, R. Moreau, P. Ginès, et al. CANONIC study investigators of the EASL-CLIF Consortium Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure J Hepatol 61 2014 1038 1047
23. P.S. Kamath, and W.R. Kim Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
24. M.M. Whitmore, A. Iparraguirre, L. Kubelka, W. Weninger, T. Hai, B.R. Williams, and et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3 J Immunol 179 2007 3622 3630
25. H. Tilg, A. Wilmer, W. Vogel, M. Herold, B. Nölchen, G. Judmaier, and et al. Serum levels of cytokines in chronic liver diseases Gastroenterology 103 1992 264 274
26. J.C. López-Talavera, A. Levitzki, M. Martínez, A. Gazit, R. Esteban, J. Guardia, and et al. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites J Clin Invest 100 1997 664 670
27. M. Navasa, A. Follo, X. Filella, W. Jiménez, A. Francitorra, R. Planas, and et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality Hepatology 27 1998 1227 1232
28. J. Genescà, R. Martí, F. Rojo, F. Campos, V. Peribáñez, A. Gónzalez, and et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites Gut 52 2003 1054 1059
29. P. Zapater, R. Francés, J.M. González-Navajas, M.A. de la Hoz, R. Moreu, S. Pascual, and et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis Hepatology 48 2008 1924 1931
30. S.M. Bagshaw, M. Bennett, M. Haase, A. Haase-Fielitz, M. Egi, H. Morimatsu, and et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness Intensive Care Med 36 2010 452 461
31. M. Wang, Q. Zhang, X. Zhao, G. Dong, and C. Li Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study Crit Care 18 2014 634
32. T. Berger, A. Togawa, G.S. Duncan, A.J. Elia, A. You-Ten, A. Wakeham, and et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury Proc Natl Acad Sci U S A 103 2006 1834 1839
33. Z. Liu, R. Petersen, and L. Devireddy Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections J Immunol 190 2013 4692 4706
34. J. Fernández, J. Acevedo, M. Castro, O. Garcia, C.R. de Lope, D. Roca, and et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study Hepatology 55 2012 1551 1561
35. R. Jalan, J. Fernández, R. Wiest, B. Schnabl, R. Moreau, P. Angeli, and et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013 J Hepatol 60 2014 1310 1324